HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Promethean Fires Up AC-11 Cosmeceutical Line With Optigenex Deal

This article was originally published in The Rose Sheet

Executive Summary

Promethean Corporation aims to launch nutritional supplements and a topical skin-care system in 2010 under a deal with Optigenex granting it access to the latter's AC-11 compound for DNA repair

You may also be interested in...



Experts Discuss Exotic Actives, Ingredient Sourcing Challenges In Amazonia

In-Cosmetics speakers agreed that sustainable sourcing and environmental protection measures are critical in the Amazon where the rich but increasingly imperiled ecosystem continues to provide skin-care formulators with exotic new ingredients for combating aging.

Experts Discuss Exotic Actives, Ingredient Sourcing Challenges In Amazonia

In-Cosmetics speakers agreed that sustainable sourcing and environmental protection measures are critical in the Amazon where the rich but increasingly imperiled ecosystem continues to provide skin-care formulators with exotic new ingredients for combating aging.

Keep An Eye On Neighboring Industries For Next Big Cosmetic Ingredient

With consumers seeking multi-dimensional sensory experiences from the goods they buy, fragrance and personal-care innovators should be looking to give-and-take with outside industries, according to Amy Marks-McGee, founder of consulting firm Trendincite

Related Content

UsernamePublicRestriction

Register

ID1131511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel